pharmaceutical care iii management of asthma angela singh, pharmd assistant professor of pharmacy...
TRANSCRIPT
Pharmaceutical Care IIIManagement of Asthma
Angela Singh, PharmDAssistant Professor of Pharmacy Practice
Florida A&M University College of Pharmacy
Overview of Asthma
• Inflammatory disease characterized by hyperresponsiveness of the airways.
• Inflammatory mediators include prostaglandins, histamine and leukotrienes.
• Inflammation results in bronchial smooth muscle spasms, vascular congestion, increased vascular permeability, mucous production and impaired ciliary function.
Case
• Chief Complaint– I have become increasingly short of breath
over the past few weeks.• HPI
– B.W is a 20 year-old woman who attends the university, majoring in business. She comes to the clinic today because she has noticed that she has been using her albuterol inhaler more frequently (3 to 4 times a week) and has also been experiencing symptoms at night more frequently (3 times/month).
Case
• SH– Denies any use of tobacco, consumes 10-12 drinks per week,
usually on the weekends, drinks one Coke daily and denies any use of illicit drugs.
• PE– Occasional expiratory wheezes bilaterally
• Diagnostic Tests– Peak expiratory flow variability is 25% and her FEV1 is 85%.
Current Medications
• Albuterol inhaler 2 puffs q 4 hours as needed for shortness of breath and/or wheezing.
• Ortho Novum as directed monthly.• Propranolol 40 mg twice daily• St. John’s Wort 300 mg three times daily.
Categories of Asthma
• Extrinsic/Allergic • Intrinsic
Etiology
• Innate Immunity
• Genetics
• Environmental Factors
Pathophysiology
• Acute Inflammation– Early response– Delayed Response
• Chronic Inflammation
• Bronchoconstriction
• Airway Hyperresponsiveness
• Airway Edema
Key Symptoms of Asthma
• Wheezing• History of any of the
following– Cough– Recurrent wheeze– Recurrent difficulty in
breathing– Recurrent chest
tightness• Symptoms occur or worsen
at night, awakening the patient
• Symptoms occur or worsen in the presence of– Exercise– Viral infection– Inhalant allergens– Irritants– Changes in weather– Strong emotional
expression– Menstrual Cycles
Co-Morbid Conditions that may Worsen Asthma
• GERD• Obesity• Obstructive Sleep Apnea (OSA)• Rhinitis• Stess/Depression
Diagnosis
• Medical History• Physical Examination• Spirometry
– Forced Vital Capacity (FVC)– Forced Expiratory Volume in one second (FEV1)
– FEV1 / FVC ratio
Diagnostic Tests
• FEV1/FVC ratio • Peak Flow Meters• Bronchoprovocation Test
Complications
• Acute
• Chronic
Classification Mild Intermittent
Mild
Persistent
Moderate Persistent
Severe Persistent
Frequency of Symptoms
< 2 days/week > 2 days/week Daily Continual
Night Time Symptoms
< 2 nights/month
> 2 nights/month
> 1 night/week Frequent
Peak Expiratory Flow Variability
< 20% 20-30% > 30% > 30%
Forced Expiratory
Volume in 1 second
> 80 % > 80% 60% to
80%
< 60%
Asthma Severity Classification
Case
• Based on her presentation how would you classify her asthma?
Treatment Goals
• Prevent chronic and troublesome symptoms
• Require infrequent use of inhaled SABA (< 2 times per week) for quick relief of symptoms (not including prevention of exercise-induced bronchospasm (EIB))
Non-Pharmacological Approaches
• Immunizations– Influenza vaccine – Doesn’t prevent asthma exacerbations during flu
season
• Allergen avoidance• Tobacco smoke, dust mites, animal dander, cockroach,
pollen, mold, exercise
• Education of the parents and the child.
Education
• Basic facts about asthma• Role of Medications• Patient Skills
– Taking medications correctly– Identifying and avoid environmental exposures– Self Monitoring – Asthma Action Plan
How to administer an inhaler…
• Take off the cap and shake the inhaler
• Breath out all the way • Hold your inhaler one of the
following ways– Hold inhaler 1 to 2 inches in
front of your mouth (about the width of two fingers)
– Use a spacer/ holding chamber. These come in many shapes and can be useful to any patient.
– Put the inhaler in your mouth.
• Breathe in slowly • As you start breathing in slowly
through your mouth, press down on the inhaler one time (If you use a holding chamber, first press down on the inhaler. Within 5 seconds, begin to breathe in slowly.
• Keep breathing in slowly, as deeply as you can.
• Hold your breath • Hold your breath as you count to
10 slowly, if you can. • Wait about 1 minute between
puffs.
Tips for Using an Inhaler
• Rinse mouth with water or mouth wash after using corticosteroid medication to prevent hoarseness and fungal infections in the mouth and throat.
• If you are taking more than one inhaled medication, it is important to take them in the correct order. Bronchodilating medications are usually taken first to open the airways and allow other types of medications to be more effectively inhaled into the lungs. Corticosteroids and cromolyn are inhaled after bronchodilating drugs.
• Avoid the use of over-the-counter inhalers. Most of these contain epinephrine, which is effective for only a short time and may cause rebound bronchospasm (making it more difficult to breathe).
• Take only the recommended number of puffs prescribed by your provider; over-use or incorrect use can be dangerous.
• Notify your doctor if any of the following occur: – You do not get relief from your metered dose inhaler – You have increasing shortness of breath despite use of inhalers – You are experiencing weakness, increased heart rate, shakiness,
insomnia, nervousness, headaches, nausea or vomiting
CFC vs HFA Inhalers
• Due to the Clean Air Act Chlorofluorocarbon (CFC) inhalers are being phased out of the market and replaced with hydrofluroalkane (HFA) inhalers.
• These inhalers require different instructions for priming, storage and use.
Pharmacologial Approaches
• Beta Agonists• Corticosteroids• Leukotriene Modifiers• Mast Cell Stabilizers• Theophylline• Monoclonal Antibodies
Short Acting Beta Agonists (SABA)Used for the Prevention and TREATMENT of Bronchospasms
Brand Name Generic Name Formulations Comments
Xopenex®
Xopenex HFA®
Pregnancy Category C
Levalbuterol Nebulizing Solution
Oral Aerosol
Store at room temperature. Protect from light. Contains 200 actuations. Vials should be used within two weeks after opening protective pouch.
Proventil HFA ®, Proair HFA ®, AccuNeb®
Ventolin HFA®
Combivent® (combination product), VoSpire ER®
Pregnancy Category C
Albuterol Oral Aerosol
Nebulizer Solution
Tablet
Extended Release Tablet
Syrup
Store at room temperature, each inhaler contains 200 actuations, Use nebulizing solution within one week of opening foil pouch.
Maxair ®
Pregnancy Category C
Pirbuterol Oral Aerosol
Autohaler
Contains 400 inhalations, Store at room temperature
Alupent®
Pregnancy Category C
Metaproterenol Oral Aerosol
Nebulizer
Syrup
Tablet
Store in a tight, light resistant container. Contains 200 actuations. Do not use if solution is brown or contains a precipitate.
Long Acting Beta Agonists (LABA)Used for the PREVENTION of bronchospasms
Brand Name Generic Name Dosage Forms Comments
Foradil®
Perforomist ®
Symbicort ® (combination product)
Pregnancy Category C
Formoterol Aerosol Powder
Nebulizing Solution
Store Foradil®
in refrigerator prior to dispensing, after dispensing store at room temperature. Remove capsules from blister pack immediately before using. Use within 4 months of purchase.
Serevent Diskus®
Advair HFA ® (combination product)
Pregnancy Category C
Salmeterol Aerosol Powder Store at room temperature away from direct light or heat. Stable for 6 weeks after removal from foil pouch. Not for the use of acute control of bronchospasms. Major substrate 3A4.
Beta Agonists
• Side Effects– Tachycardia– Insomnia– Nervousness– Hypokalemia– Hyperglycemia– Diarrhea– Dry Mouth– Tremors
• Drug Interactions– MAOIs– Sympathomimetic Agents– Beta Blockers– P450 3A4 Inhibitors &
Inducers• Salmeterol
– Caffeine– Yohimbine
Spacing Devices
CorticosteroidsGeneric Name Brand Name Formulations
Beclomethasone
Pregnancy Category C
QVAR ® Oral Aerosol
100 Actuations
Traimcinolone
Pregnancy Category C
Azmacort ®, Oral Aerosol
240 actuations
Flunisolide
Pregnancy Category C
Aerobid ® Aerospan HFA Oral Aerosol
100 actuations
Fluticasone
Pregnancy Category C
Flovent HFA ®
Flovent Diskus ®
Advair ®
Oral Aerosol
120 actuations
Mometasone
Pregnancy Category C
Asmanex ® Aerosol Powder
200 Actuations
Budesonide
Pregnancy Category B
Pulmicort Flexhaler ®
Pulmicort Respules ®
Symbicort ®
Aerosol Powder
120 Actuations
Nebulizer
Corticosteroids
• Oral Agents– Prednisone– Methylprednisilone– Prednisilone
• Adverse Effects– Oral candidiasis– Hoarseness– May slow bone growth in
children.– Cushing’s Effects– Osteoporosis– Hypertension– Cataracts– Glucose Intolerance– Skin Thinning– Depression
• Comments– Use SPACERS to minimize
local and systemic adverse effects.
– RINSE MOUTH with water after inhalations to prevent thrush infections.
– Use steroid inhalers as scheduled not as needed.
– Consider calcium and Vitamin D supplementation.
– Pulmicort Respules is the only nebulized approved steroid.
Corticosteroids: Drug Interactions
• Anti-diabetic agents
• 3A4 Inhibitors & Inducers– Flunisolide, Fluticasone, Mometasone,
Budesonide
Brand Name Generic Name Formulations
Intal Cromolyn Sodium
Oral Aerosol
200 actuations
Nebulizing Solution
Mast Cell Stabilizer
Mast Cell Stabilizers
• Adverse Effects– Unpleasant taste– Cough
• Drug Interactions– No significant drug
interactions
• Comments– Slow onset: may take 4-8
weeks for expected effect.– Alternative to steroids in
children.– Not for rapid relief.
Theophyilline ( Theodur, Uniphyl, Theo-24)
• Dose 10 mg/kg/day given BID-TID with a maximum dose of 900 mg daily.
• Therapeutic Levels– 5-15 mcg/mL
• Formulations– Controlled Release Tablet (Uniphyl)– Extended Release Capsule (Theo-24)– Elixir (Elixophyllin)
• Side Effects– Nausea– Vomiting– Nervousness– Tremors– Insomnia– Headache– Arrhythmia– Seizures
Theophylline cont.
• Drug Interactions– 3A4 and 1A2 Inhibitors &
Inducers– Caffeine
• Comments– Beneficial for night
symptoms.– Not for acute relief.
Leukotriene Modifiers
Generic Name Brand Name Formulation
Montelukast Singulair Tablets
Chewable Tablets
Granules
Zafirlukast Accolate Tablets
Leukotriene Modifiers
• Drug Interactions– Montelukast
• Inhibitors & Inducers of 2C9 & 3A4.
– Zafirlukast• Inhibits 2C9, 3A4• Inhibitors & Inducers of
2C9 (it is a major substrate).
• Adverse effects– Hepatotoxicity
• Liver function tests at baseline, every month x 3 months for one year
– Headache– GI Upset
Zileuton (Zyflo®)
• Inhibits the production of leukotrienes.
• Available as an extended release tablet
• Useful in mild persistent asthma and in combination with corticosteroids in moderate persistent asthma.
• Used in pateints > 12 years of age.
• Adverse Effects– Elevated liver enzymes.– Monitor hepatic enzymes
• Drug Interactions– Zileuton is a 1A2 and 3A4
inhibitor.
Omalizumab ( Xolair)
• Monoclonal antibody that acts by inhibiting IgE binding to mast cells and basophils.
• Administered subcutaneously every 2-4 weeks
• Must be refrigerated.
• Helpful in moderate to severe persistent allergy-related asthma.
• Use in > 12 years old• Second line therapy• Very expensive
Omalizumab (Xolair)
• Drug Interactions– No significant drug
interactions
• Adverse Effects– Injection site reaction– Urticaria– Thrombocytopenia– Anaphylaxis
Case
• Based on her medication profile are there any medications that may be interfering with the efficacy of albuterol? Are there any drug interactions within her profile?
Stepwise Approach to Asthma
• Intermittent = Step 1
• Mild = Step 2
• Moderate = Step 3 or Step 4
• Severe = Step 5 or Step 6
Stepwise Approach of Management of Asthma
Management of Exacerbations
• Assess Severity• Initial treatment
– Short acting beta agonist
• Good Response • Incomplete Response• Poor Response
Questions
• Angela Singh• [email protected]• 599-3359• Office # 345